Dec 4 (Reuters) - Australian shares are likely to edge lower on Friday, snapping a three-day gain as risk appetite was dented by reports that Pfizer (NYSE:PFE), with whom Australia has a COVID-19 vaccine supply agreement, had slashed its vaccine rollout target on supply-chain obstacles. local share price index futures YAPcm1 fell 0.1%, a 4.3-point discount to the underlying S&P/ASX 200 index .AXJO close. The benchmark added 0.4% on Thursday.
Meanwhile New Zealand's benchmark S&P/NZX 50 index .NZ50 rose 0.2% in early trade on Friday.